The Beta Cell Therapy Grand Challenge will support research focused on the development of approaches that will restore beta cell function in people living with type 1 diabetes.
Amount: Applications led by an individual clinical or non-clinical group leaders: up to £1.5M; Applications jointly led by up to three group leaders: £2-3M
Duration: 3-5 years
Location: UK and European Researchers – Principal Applicant must be based in the UK
Process: 2-stages – 1) Expression of interest; If shortlisted : 2) Full Application and Interview
Expression of Interest Deadline: 28 April 2023; Full Application Deadline : 14 August 2023 and Interviews : w/c 2 October 2023
This call is focused on translation. This is designed to provide the injection of funds needed to fast-track burgeoning beta cell ideas towards the clinic.
Applications submitted under this call should focus on beta cell replacement and regeneration for the treatment of type 1 diabetes. The Beta Cell Therapy Scientific Advisory Panel has identified two themes to be addressed by this call.